Cargando…
P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431311/ http://dx.doi.org/10.1097/01.HS9.0000846636.06566.b4 |
| _version_ | 1784780019355090944 |
|---|---|
| author | Usmani, S. Z. Mielnik, M. Koh, Y. Alonso Alonso, A. Leleu, X. Quach, H. Min, C.-K. Janowski, W. Abdallah, A.-O. Garg, M. Sandhu, I. Ocio San Miguel, E. M. Oriol, A. Rodriquez-Otero, P. Ramasamy, K. Weisel, K. Besemer, B. Cavo, M. Zhou, X. L. Kaisermann, M. C. Bego Marques, C. M. Williams, D. Carreno, F. Kremer, B. E. Gupta, I. V. Hus, M. |
| author_facet | Usmani, S. Z. Mielnik, M. Koh, Y. Alonso Alonso, A. Leleu, X. Quach, H. Min, C.-K. Janowski, W. Abdallah, A.-O. Garg, M. Sandhu, I. Ocio San Miguel, E. M. Oriol, A. Rodriquez-Otero, P. Ramasamy, K. Weisel, K. Besemer, B. Cavo, M. Zhou, X. L. Kaisermann, M. C. Bego Marques, C. M. Williams, D. Carreno, F. Kremer, B. E. Gupta, I. V. Hus, M. |
| author_sort | Usmani, S. Z. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431311 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94313112022-08-31 P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA Usmani, S. Z. Mielnik, M. Koh, Y. Alonso Alonso, A. Leleu, X. Quach, H. Min, C.-K. Janowski, W. Abdallah, A.-O. Garg, M. Sandhu, I. Ocio San Miguel, E. M. Oriol, A. Rodriquez-Otero, P. Ramasamy, K. Weisel, K. Besemer, B. Cavo, M. Zhou, X. L. Kaisermann, M. C. Bego Marques, C. M. Williams, D. Carreno, F. Kremer, B. E. Gupta, I. V. Hus, M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431311/ http://dx.doi.org/10.1097/01.HS9.0000846636.06566.b4 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Usmani, S. Z. Mielnik, M. Koh, Y. Alonso Alonso, A. Leleu, X. Quach, H. Min, C.-K. Janowski, W. Abdallah, A.-O. Garg, M. Sandhu, I. Ocio San Miguel, E. M. Oriol, A. Rodriquez-Otero, P. Ramasamy, K. Weisel, K. Besemer, B. Cavo, M. Zhou, X. L. Kaisermann, M. C. Bego Marques, C. M. Williams, D. Carreno, F. Kremer, B. E. Gupta, I. V. Hus, M. P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title | P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_full | P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_fullStr | P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_full_unstemmed | P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_short | P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_sort | p942: dreamm-9: phase i study of belantamab mafodotin plus standard of care in patients with transplant-ineligible newly diagnosed multiple myeloma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431311/ http://dx.doi.org/10.1097/01.HS9.0000846636.06566.b4 |
| work_keys_str_mv | AT usmanisz p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT mielnikm p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT kohy p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT alonsoalonsoa p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT leleux p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT quachh p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT minck p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT janowskiw p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT abdallahao p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT gargm p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT sandhui p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT ociosanmiguelem p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT oriola p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT rodriquezoterop p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT ramasamyk p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT weiselk p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT besemerb p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT cavom p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT zhouxl p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT kaisermannmc p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT begomarquescm p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT williamsd p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT carrenof p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT kremerbe p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT guptaiv p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma AT husm p942dreamm9phaseistudyofbelantamabmafodotinplusstandardofcareinpatientswithtransplantineligiblenewlydiagnosedmultiplemyeloma |